ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors Feb 21, 2019 07:30AM
Emisphere Amends License Agreement with Novo Nordisk Apr 26, 2018 08:30AM
Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement Oct 15, 2015 08:21AM
Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement Oct 15, 2015 08:21AM